Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired Paxlovid labeled for emergency use to patients through March 8, after which Paxlovid labeled for emergency use must be returned to the manufacturer or disposed of in accord with regulations, the agency said.

The FDA last May approved a new drug application for Pfizer’s Paxlovid to treat adults at high risk of progressing to severe COVID-19. Paxlovid labeled under the new drug application will continue to be authorized for emergency use to treat eligible pediatric patients, the agency said.
 

Related News Articles

Headline
The Department of Agriculture March 20 announced it will fund up to $100 million for projects exploring prevention, therapeutics, research and potential…
Headline
There are 378 confirmed cases of measles in 17 states across the country, according to the latest data from the Centers for Disease Control and Prevention. The…
Headline
There have been 301 confirmed cases of measles across the U.S. so far this year, surpassing the 2024 total of 285, according to the latest data from the…
Headline
The Centers for Disease Control and Prevention today released a health advisory on the measles outbreak in Texas and New Mexico. As of today, Texas has…
Headline
The Centers for Disease Control and Prevention March 4 announced it sent agency experts to Texas to assist local officials in responding to the state’s measles…
Headline
A school-aged child in Texas is the first reported individual to die from measles amid an outbreak in the South Plains and Panhandle regions of the state, the…